Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
Coffee mug company builds high-tech box to keep vaccines cold
Smart mug company Ember has created a shipping container to help bolster the medicine cold chain.
Smartphone COVID test is as accurate as PCR test
Researchers created a smartphone-based test kit that will test for the viruses that cause COVID and flu. Early research has shown that the kit is as accurate as standard lab-based testing but much faster.
Bionic eye implants enable a blind person to see again
Doctors successfully implanted a microchip in a woman’s retina, restoring some vision to her blind eye.
Magnetic “seed” heats and kills tumors in new cancer therapy
A novel cancer therapy uses a magnetic “seed” to precisely target and kill brain tumor cells without the need for open brain surgery.
MIT tests pill to deliver RNA vaccines and therapies
A tortoise-inspired capsule designed by MIT can deliver RNA vaccines and other nucleic acid therapeutics without injections.
Researchers can predict rats’ behavior by reading their brains
A team at the University of Oregon have decoded the patterns of brain activity to predict basic actions in mice.
Cataract surgery associated with lower risk of dementia
In a new study of thousands of patients, those who had cataract surgery had a reduction in dementia risk.
Guinea worm disease is near eradication, Carter Center says
After decades of work, cases of human Guinea worm disease are in the double digits — putting elimination of the painful infection in sight.
Drug that cleans up cholesterol may reduce post stroke dementia
Researchers look to an FDA-approved drug ingredient that can “scoop-up” and store cholesterol and possibly stave off post stroke dementia.
Surgery robot outperforms humans at “keyhole surgery”
Johns Hopkins’ autonomous surgery robot, STAR, performed a tricky keyhole surgery on live pigs better than a human surgeon could.
“BioDome” triggers near-complete limb regeneration in frogs
A new limb regeneration treatment allowed adult African clawed frogs to regrow near-complete functional legs following amputation.
Gene therapy shows promise at treating severe form of epilepsy
A new Dravet syndrome treatment that targets genes could help extend the lives of people with the rare, but severe form of epilepsy.
Harm reduction vending machines are coming to New York
New York City has announced a pilot program installing public health vending machines with overdose drugs and clean needles.
Mark Cuban launches online pharmacy to cut drug prices
Billionaire investor Mark Cuban has launched an online pharmacy designed to cut the cost of generic drugs by as much as 99%.
Ketamine therapy may help former drinkers stay abstinent
A new study has found evidence that ketamine, combined with therapy, can help people with alcohol addiction abstain longer.
Are stem cells about to cure baldness?
Researchers have reprogrammed stem cells to successfully grow human hair on animals, hinting at a potential cure for baldness.
Pig kidneys transplanted into body of brain-dead man
A brain-dead man was the recipient of two pig kidneys — a groundbreaking transplant that could help bring the organ shortage to an end.
Beet juice “blood” is a potent way to kill mosquitoes
Molecular Attraction plans to kill mosquitoes transmitting malaria by tricking them into drinking beet juice “blood” laced with toxins.
Scientists discover possible precursor to a Parkinson’s drug
Scientists have optimized a peptide known to prevent the “protein misfolding,” that causes Parkinson’s disease. This could be a precourser to a disease treatment.
You can finally order free COVID-19 tests online
Every American household can now request four free COVID-19 tests from the U.S. government using a newly launched website.
Subscribe to the newsletter